Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
2.090
+0.030 (1.46%)
At close: Nov 22, 2024, 4:00 PM
2.070
-0.020 (-0.96%)
After-hours: Nov 22, 2024, 4:15 PM EST
Fractyl Health Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fractyl Health stock has a target of 18, which predicts an increase of 761.24% from the current stock price of 2.09.
Analyst Consensus: Buy
* Price targets were last updated on Feb 27, 2024.
Analyst Ratings
The average analyst rating for Fractyl Health stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|
| Strong Buy | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 28, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $18 | Buy | Initiates | $18 | +761.24% | Feb 27, 2024 |
Financial Forecast
Revenue This Year
15.30K
from 120.00K
Decreased by -87.25%
Revenue Next Year
n/a
from 15.30K
EPS This Year
-1.36
from -45.29
EPS Next Year
-2.53
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 31,500 | n/a | 13.1M |
| Avg | 15,300 | n/a | 12.7M |
| Low | n/a | n/a | 12.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -73.8% | - | - |
| Avg | -87.3% | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.40 | -2.32 | -3.21 |
| Avg | -1.36 | -2.53 | -3.12 |
| Low | -1.30 | -2.70 | -3.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.